AXS

AXS Stock -- What's In It For Investors?

A strong performer from today's morning trading session is Axis Capital, whose shares rose 2.7% to $57.13 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

A Lower P/B Ratio Than Its Sector Average but Trades Above Its Graham Number:

AXIS Capital Holdings Limited, through its subsidiaries, provides various specialty insurance and reinsurance products worldwide. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 14.34 and an average price to book (P/B) ratio of 1.57. In contrast, Axis Capital has a trailing 12 month P/E ratio of 14.4 and a P/B ratio of 1.09.

When we divideAxis Capital's P/E ratio by its expected five-year EPS growth rate, we obtain a PEG ratio of 0.33, which indicates that the market is undervaluing the company's projected growth (a PEG ratio of 1 indicates a fairly valued company). Your analysis of the stock shouldn't end here. Rather, a good PEG ratio should alert you that it may be worthwhile to take a closer look at the stock.

The Business Runs With Low Debt Levels:

2018-02-28 2019-02-26 2020-02-27 2021-02-26 2022-02-25 2023-01-27
Revenue (MM) $4,592 $5,090 $5,173 $4,842 $5,322 $5,135
Interest Income (MM) -$55 -$67 -$68 -$75 -$62 -$63
Operating Margins -2% 6% 8% 1% 13% 4%
Net Margins -8% 1% 6% -2% 12% 4%
Net Income (MM) -$369 $43 $323 -$120 $619 $223
Depreciation & Amort. (MM) -$81 -$182 -$75 -$66 -$67 -$68
Earnings Per Share -$4.14 $0.0 $3.35 -$1.79 $6.87 $2.29
EPS Growth n/a 100.0% n/a -153.43% 483.8% -66.67%
Diluted Shares (MM) 100 84 84 84 86 84
Long Term Debt (MM) $1,377 n/a n/a n/a $1,311 $1,394
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS